Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours

[1]  A. Cerami,et al.  Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.

[2]  S. Weiss,et al.  Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes , 1988, Journal of Neuroimmunology.

[3]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[4]  C. Brosnan,et al.  Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis , 1988, Journal of Neuroimmunology.

[5]  E. A. Havell,et al.  The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma , 1988, The Journal of experimental medicine.

[6]  B. Tavolato,et al.  Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG , 1988, Journal of the Neurological Sciences.

[7]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[8]  B. Beutler,et al.  Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. , 1988, Endocrine reviews.

[9]  M. Shin,et al.  Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. , 1987, Journal of immunology.

[10]  V. ter meulen,et al.  Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[12]  B. Beutler,et al.  Cachectin: more than a tumor necrosis factor. , 1987, The New England journal of medicine.

[13]  M. E. Carver,et al.  Serum-free in vitro bioassay for the detection of tumor necrosis factor. , 1986, Journal of immunological methods.

[14]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[15]  R. Redfield,et al.  The Walter Reed staging classification for HTLV-III/LAV infection. , 1986, The New England journal of medicine.

[16]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[17]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[18]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[19]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Tavolato,et al.  Central nervous system involvement in HIV infection. , 1988, AIDS research and human retroviruses.

[21]  N. Matthews,et al.  Studies on the Mode of Action of Tumor Necrosis Factor on Tumor Cells In Vitro , 1987 .

[22]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[23]  B. Beutler,et al.  Cachectin: A Monokine Implicated as a Mediator of Cachexia and Shock , 1987 .